A Safety Study of LY3526318 in Healthy Participants

NCT04682119 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3526318
DRUG: Placebo

Sponsor

Eli Lilly and Company